BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2302 related articles for article (PubMed ID: 29102084)

  • 1. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project).
    Lu J; Lu Y; Wang X; Li X; Linderman GC; Wu C; Cheng X; Mu L; Zhang H; Liu J; Su M; Zhao H; Spatz ES; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
    Lancet; 2017 Dec; 390(10112):2549-2558. PubMed ID: 29102084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, Awareness, and Treatment of Isolated Diastolic Hypertension: Insights From the China PEACE Million Persons Project.
    Mahajan S; Zhang D; He S; Lu Y; Gupta A; Spatz ES; Lu J; Huang C; Herrin J; Liu S; Yang J; Wu C; Cui J; Zhang Q; Li X; Nasir K; Zheng X; Krumholz HM; Li J; ;
    J Am Heart Assoc; 2019 Oct; 8(19):e012954. PubMed ID: 31566101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Awareness, treatment and control of hypertension in 640 000 adults in eastern China].
    Yan XF; Yang JW; Bai XK; Wang HR; Feng F; Hou LL; Sun Y; Wang WJ; Li X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jan; 41(1):68-73. PubMed ID: 32062945
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary care institutional characteristics associated with hypertension awareness, treatment, and control in the China PEACE-Million Persons Project and primary health-care survey: a cross-sectional study.
    ; Zhou T; Wang Y; Zhang H; Wu C; Tian N; Cui J; Bai X; Yang Y; Zhang X; Lu Y; Spatz ES; Ross JS; Krumholz HM; Lu J; Li X; Hu S
    Lancet Glob Health; 2023 Jan; 11(1):e83-e94. PubMed ID: 36521957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015.
    Wang Z; Chen Z; Zhang L; Wang X; Hao G; Zhang Z; Shao L; Tian Y; Dong Y; Zheng C; Wang J; Zhu M; Weintraub WS; Gao R;
    Circulation; 2018 May; 137(22):2344-2356. PubMed ID: 29449338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trends in prevalence, awareness, treatment and control of hypertension in middle-aged Chinese population].
    Wang ZW; Wu YF; Zhao LC; Li Y; Yang J; Zhou BF;
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):407-11. PubMed ID: 15231166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Prevalence, Awareness, and Characteristics of Isolated Systolic Hypertension Among Younger and Middle-Aged Adults in China.
    Mahajan S; Feng F; Hu S; Lu Y; Gupta A; Murugiah K; Gao Y; Lu J; Liu J; Zheng X; Spatz ES; Zhang H; Krumholz HM; Li J
    JAMA Netw Open; 2020 Dec; 3(12):e209743. PubMed ID: 33289843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, awareness, treatment, and control of hypertension in china.
    Gu D; Reynolds K; Wu X; Chen J; Duan X; Muntner P; Huang G; Reynolds RF; Su S; Whelton PK; He J;
    Hypertension; 2002 Dec; 40(6):920-7. PubMed ID: 12468580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey.
    Su M; Zhang Q; Bai X; Wu C; Li Y; Mossialos E; Mensah GA; Masoudi FA; Lu J; Li X; Salas-Vega S; Zhang A; Lu Y; Nasir K; Krumholz HM; Jiang L
    Lancet; 2017 Dec; 390(10112):2559-2568. PubMed ID: 29102087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence, awareness, treatment and control of hypertension in Chinese adults].
    Gu DF; Jiang H; Wu XG; Reynolds K; Gan WQ; Liu DH; Su SY; Duan XF; Huang GY; Whelton PK
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):84-9. PubMed ID: 12839656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hypertension in China: results from the China PEACE million persons project.
    Li J
    J Hypertens; 2021 Mar; 39(3):461-470. PubMed ID: 33038086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, awareness, medication, control, and risk factors associated with hypertension in Yi ethnic group aged 50 years and over in rural China: the Yunnan minority eye study.
    Chen L; Zong Y; Wei T; Sheng X; Shen W; Li J; Niu Z; Zhou H; Zhang Y; Yuan Y; Chen Q; Zhong H
    BMC Public Health; 2015 Apr; 15():383. PubMed ID: 25886600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of hypertension in China: A nationally representative survey of 174,621 adults.
    Li Y; Yang L; Wang L; Zhang M; Huang Z; Deng Q; Zhou M; Chen Z; Wang L
    Int J Cardiol; 2017 Jan; 227():516-523. PubMed ID: 27856040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey.
    Zhang M; Shi Y; Zhou B; Huang Z; Zhao Z; Li C; Zhang X; Han G; Peng K; Li X; Wang Y; Ezzati M; Wang L; Li Y
    BMJ; 2023 Jan; 380():e071952. PubMed ID: 36631148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.
    NCD Risk Factor Collaboration (NCD-RisC)
    Lancet; 2021 Sep; 398(10304):957-980. PubMed ID: 34450083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, awareness, treatment, control, and risk factors associated with hypertension in urban adults from 33 communities of China: the CHPSNE study.
    Meng XJ; Dong GH; Wang D; Liu MM; Lin Q; Tian S; Xu LX; Hou H; Ren YF; Lee YL
    J Hypertens; 2011 Jul; 29(7):1303-10. PubMed ID: 21558952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on effects of community-based management of hypertension patients aged ≥35 years and influencing factors in urban and rural areas of China, 2010].
    Zeng XY; Zhang M; Li YC; Huang ZJ; Wang LM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 May; 37(5):612-7. PubMed ID: 27188348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China.
    Li W; Gu H; Teo KK; Bo J; Wang Y; Yang J; Wang X; Zhang H; Sun Y; Jia X; He X; Zhao X; Cheng X; Li J; Rangarajan S; Chen C; Yusuf S; Liu L;
    J Hypertens; 2016 Jan; 34(1):39-46. PubMed ID: 26630211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries.
    Chow CK; Teo KK; Rangarajan S; Islam S; Gupta R; Avezum A; Bahonar A; Chifamba J; Dagenais G; Diaz R; Kazmi K; Lanas F; Wei L; Lopez-Jaramillo P; Fanghong L; Ismail NH; Puoane T; Rosengren A; Szuba A; Temizhan A; Wielgosz A; Yusuf R; Yusufali A; McKee M; Liu L; Mony P; Yusuf S;
    JAMA; 2013 Sep; 310(9):959-68. PubMed ID: 24002282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension prevalence, awareness, treatment, and control in northeast China: a population-based cross-sectional survey.
    Zhang FL; Guo ZN; Xing YQ; Wu YH; Liu HY; Yang Y
    J Hum Hypertens; 2017 Dec; 32(1):54-65. PubMed ID: 29180804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 116.